215 related articles for article (PubMed ID: 37128730)
1. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
McNamee M; Wong S; Guy O; Sharma S
Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
[TBL] [Abstract][Full Text] [Related]
2. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
3. An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
Xia D; Jin R; Byagathvalli G; Yu H; Ye L; Lu CY; Bhamla MS; Yang C; Prausnitz MR
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34670842
[TBL] [Abstract][Full Text] [Related]
4. Microneedle Systems for Vaccine Delivery: the story so far.
Hossain MK; Ahmed T; Bhusal P; Subedi RK; Salahshoori I; Soltani M; Hassanzadeganroudsari M
Expert Rev Vaccines; 2020 Dec; 19(12):1153-1166. PubMed ID: 33427523
[TBL] [Abstract][Full Text] [Related]
5. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
6. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
7. Progress in microneedle array patch (MAP) for vaccine delivery.
Nguyen TT; Oh Y; Kim Y; Shin Y; Baek SK; Park JH
Hum Vaccin Immunother; 2021 Jan; 17(1):316-327. PubMed ID: 32667239
[TBL] [Abstract][Full Text] [Related]
8. Microneedle-Based Vaccine Delivery: Review of an Emerging Technology.
Mansoor I; Eassa HA; Mohammed KHA; Abd El-Fattah MA; Abdo MH; Rashad E; Eassa HA; Saleh A; Amin OM; Nounou MI; Ghoneim O
AAPS PharmSciTech; 2022 Apr; 23(4):103. PubMed ID: 35381906
[TBL] [Abstract][Full Text] [Related]
9. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
[No Abstract] [Full Text] [Related]
10. Microneedles: A New Generation Vaccine Delivery System.
Menon I; Bagwe P; Gomes KB; Bajaj L; Gala R; Uddin MN; D'Souza MJ; Zughaier SM
Micromachines (Basel); 2021 Apr; 12(4):. PubMed ID: 33919925
[TBL] [Abstract][Full Text] [Related]
11. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
[TBL] [Abstract][Full Text] [Related]
12. [Microneedle-based percutaneous immunity: a review].
Li Y; Wang J; Jin Z; Wan W; Bai X; Hu C; Li Y; Xin W; Kang L; Yang H; Wang J; Gao S
Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3301-3315. PubMed ID: 36151801
[TBL] [Abstract][Full Text] [Related]
13. Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice.
Carey JB; Pearson FE; Vrdoljak A; McGrath MG; Crean AM; Walsh PT; Doody T; O'Mahony C; Hill AV; Moore AC
PLoS One; 2011; 6(7):e22442. PubMed ID: 21799855
[TBL] [Abstract][Full Text] [Related]
14. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
[TBL] [Abstract][Full Text] [Related]
15. Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays.
Allen LV
Int J Pharm Compd; 2023; 27(1):30-37. PubMed ID: 36720061
[TBL] [Abstract][Full Text] [Related]
16. Microneedle-mediated delivery of viral vectored vaccines.
Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
[TBL] [Abstract][Full Text] [Related]
17. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
Wang T; Wang N
Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents.
Marshall S; Fleming A; Moore AC; Sahm LJ
Vaccine; 2017 Sep; 35(37):4896-4904. PubMed ID: 28780122
[TBL] [Abstract][Full Text] [Related]
19. Microarray patches: scratching the surface of vaccine delivery.
Choo JJY; McMillan CLD; Young PR; Muller DA
Expert Rev Vaccines; 2023; 22(1):937-955. PubMed ID: 37846657
[TBL] [Abstract][Full Text] [Related]
20. Microneedle technologies for (trans)dermal drug and vaccine delivery.
van der Maaden K; Jiskoot W; Bouwstra J
J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
